| Net income | |
| Depreciation and amortization | |
| Net amortization of premiums on securities | 2.33M |
| Provision for loan losses | 6.28M |
| Share-based compensation | 597K |
| Deferred income tax expense | -523K |
| Proceeds from sale of loans held for sale | 9.25M |
| Originations of loans held for sale | -8.46M |
| Increase in company owned life insurance | -2.34M |
| Net gain on sale of loans held for sale | -202K |
| Net gain on disposal of investment securities | -2.43M |
| Impairment charges on investment securities | |
| Net gain on sale and disposal of other assets | |
| Decrease in other assets | 3.55M |
| Increase in other liabilities | 1.94M |
| Net cash provided by operating activities | |
| Available for sale | -192.14M |
| Held to maturity | -90.6M |
| Available for sale | 107.42M |
| Held to maturity | 48.42M |
| Proceeds from sales and calls of securities available for sale | 85.77M |
| Net loan originations | -204.69M |
| Purchases of company owned life insurance | |
| Proceeds from sales of other assets | 602K |
| Purchases of premises and equipment | -4.24M |
| Net cash used in investing activities | |
| Net (decrease) increase in deposits | 332.83M |
| Net increase (decrease) in short-term borrowings | -62.9M |
| Repayments of long-term borrowings | |
| Proceeds from issuance of common stock, net of issuance costs | |
| Purchases of common stock for treasury | 0 |
| Repurchase of warrant issued to U.S. Treasury | |
| Redemption of Series A preferred stock | |
| Repurchase of Series B-1 8.48% preferred stock | |
| Proceeds from stock options exercised | 814K |
| Excess tax benefit on share-based compensation | 10K |
| Cash dividends paid to preferred shareholders | |
| Cash dividends paid to common shareholders | |
| Net cash provided by financing activities | |
| Net increase in cash and cash equivalents | 50.6M |
| Cash and cash equivalents, beginning of period | |
| Cash and cash equivalents, end of period | |